Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension

ClinicalTrials.gov ID: NCT00060931

Public ClinicalTrials.gov record NCT00060931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 10:11 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients With Type II Diabetes Mellitus.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure

Study identification

NCT ID
NCT00060931
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
501 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2001 (Type not available)
Primary completion
Apr 2004 (Actual)
Completion
Apr 2004 (Actual)
Last update posted
Apr 14, 2015

2001 – 2004

United States locations

U.S. sites
119
U.S. states
24
U.S. cities
100
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35211 —
GSK Investigational Site Birmingham Alabama 35294-0012 —
GSK Investigational Site Birmingham Alabama 35294-2041 —
GSK Investigational Site Columbia Alabama 35051 —
GSK Investigational Site Mobile Alabama 36608 —
GSK Investigational Site Derby Connecticut 06418 —
GSK Investigational Site Farmington Connecticut 06030 - 1410 —
GSK Investigational Site Hartford Connecticut 06106 —
GSK Investigational Site New Britain Connecticut 06050 —
GSK Investigational Site Newark Delaware 19713 —
GSK Investigational Site Washington D.C. District of Columbia 20037 —
GSK Investigational Site Washington D.C. District of Columbia 20422 —
GSK Investigational Site Coral Gables Florida 33134 —
GSK Investigational Site Fort Lauderdale Florida 33308 —
GSK Investigational Site Fort Lauderdale Florida 33316 —
GSK Investigational Site Fort Meyers Florida 33907 —
GSK Investigational Site Gainesville Florida 32605 —
GSK Investigational Site Hollywood Florida 33021 —
GSK Investigational Site Hollywood Florida 33023 —
GSK Investigational Site Inverness Florida 34452 —
GSK Investigational Site Jacksonville Florida 32205 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Melbourne Florida 32901 —
GSK Investigational Site Miami Florida 33133 —
GSK Investigational Site Miami Florida 33136 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site Miami Florida 33176 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Ocala Florida 34474 —
GSK Investigational Site Pembroke Pines Florida 33024 —
GSK Investigational Site Saint Petersberg Florida 33705 —
GSK Investigational Site Sarasota Florida 34239 —
GSK Investigational Site Tamarac Florida 33321 —
GSK Investigational Site Tampa Florida 33614 —
GSK Investigational Site Augusta Georgia 30901 —
GSK Investigational Site Fayetteville Georgia 30214 —
GSK Investigational Site Lawrenceville Georgia 30045 —
GSK Investigational Site Savannah Georgia 31406 —
GSK Investigational Site Chicago Illinois 60616 —
GSK Investigational Site West Evanston Illinois 60202 —
GSK Investigational Site Newburgh Indiana 47630 —
GSK Investigational Site Wabash Indiana 46992 —
GSK Investigational Site Lexington Kentucky 40508 —
GSK Investigational Site New Orleans Louisiana 70112 —
GSK Investigational Site New Orleans Louisiana 70121 —
GSK Investigational Site Auburn Maine 04210 —
GSK Investigational Site Bangor Maine 04401 —
GSK Investigational Site Baltimore Maryland 21204 —
GSK Investigational Site Baltimore Maryland 21208 —
GSK Investigational Site Ayer Massachusetts 01432 —
GSK Investigational Site Boston Massachusetts 02115 —
GSK Investigational Site Haverhill Massachusetts 01831-2451 —
GSK Investigational Site Springfield Massachusetts 01107 —
GSK Investigational Site Waltham Massachusetts 02453 —
GSK Investigational Site Worcester Massachusetts 01605 —
GSK Investigational Site Worcester Massachusetts 01610 —
GSK Investigational Site Waterford Michigan 48328 —
GSK Investigational Site Gulfport Mississippi 39501 —
GSK Investigational Site Camden New Jersey 08103 —
GSK Investigational Site Hackensack New Jersey 07601 —
GSK Investigational Site Linwood New Jersey 08221 —
GSK Investigational Site Margate City New Jersey 08402 —
GSK Investigational Site Sea Girt New Jersey 08750 —
GSK Investigational Site Voorhees Township New Jersey 08043 —
GSK Investigational Site Buffalo New York 14209 —
GSK Investigational Site Flushing New York 11365 —
GSK Investigational Site Fulton New York 13069 —
GSK Investigational Site Kingston New York 12401 —
GSK Investigational Site Lancaster New York 14043 —
GSK Investigational Site Liverpool New York 13088 —
GSK Investigational Site New Hyde Park New York 11040 —
GSK Investigational Site New York New York 10021 —
GSK Investigational Site New York New York 10028 —
GSK Investigational Site New York New York 10032 —
GSK Investigational Site Rochester New York 14609 —
GSK Investigational Site Scarsdale New York 10583 —
GSK Investigational Site Syracuse New York 13202 —
GSK Investigational Site The Bronx New York 10461 —
GSK Investigational Site The Bronx New York 10467 —
GSK Investigational Site Tonawanda New York 14150 —
GSK Investigational Site Williamsville New York 14221 —
GSK Investigational Site Durham North Carolina 27710 —
GSK Investigational Site Hickory North Carolina 28601 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Statesville North Carolina 28677 —
GSK Investigational Site Wilmington North Carolina 28412 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Canton Ohio 44708 —
GSK Investigational Site Cincinnati Ohio 45246 —
GSK Investigational Site Cleveland Ohio 44106 —
GSK Investigational Site Columbus Ohio 43212 —
GSK Investigational Site Zanesville Ohio 43701 —
GSK Investigational Site Camp Hill Pennsylvania 17011 —
GSK Investigational Site Connellsville Pennsylvania 15425 —
GSK Investigational Site Downington Pennsylvania 19335 —
GSK Investigational Site Erie Pennsylvania 16505 —
GSK Investigational Site Fleetwood Pennsylvania 19522 —
GSK Investigational Site Morrisville Pennsylvania 19067 —
GSK Investigational Site Philadelphia Pennsylvania 19104 —
GSK Investigational Site Philadelphia Pennsylvania 19107 —
GSK Investigational Site Philipsburg Pennsylvania 16966 —
GSK Investigational Site Pittsburgh Pennsylvania 15206 —
GSK Investigational Site Pittsburgh Pennsylvania 15241 —
GSK Investigational Site West Grove Pennsylvania 19390 —
GSK Investigational Site Columbia South Carolina 29201 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Summerville South Carolina 29485 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Jackson Tennessee 38301 —
GSK Investigational Site Memphis Tennessee 38163 —
GSK Investigational Site Nashville Tennessee 37212 —
GSK Investigational Site White River Junction Utah 05009 —
GSK Investigational Site Christiansburg Virginia 24073 —
GSK Investigational Site Falls Church Virginia 22044 —
GSK Investigational Site Fredericksburg Virginia 20401 —
GSK Investigational Site Richmond Virginia 23220 —
GSK Investigational Site Richmond Virginia 23294 —
GSK Investigational Site Salem Virginia 24153 —
GSK Investigational Site Springfield Virginia 22151 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00060931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2015 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00060931 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →